OpenBilldrug price receipt

NADAC week of 2026-10-14

ASTAGRAF XL 0.5 MG CAPSULE

FDA nonproprietary name: tacrolimus extended-release capsules

For 30 capsules

Pharmacies pay

$86.45 filed

30 × $2.88173 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$271.59 filed

30 × $9.05312 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.1× estimated

Medicare paid 3.1× what pharmacies pay.

Part D averages every strength and form sold under “Astagraf XL” / “Tacrolimus” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$104.42 estimated

$86.45 + $12.97 (15%) + $5.00 fee per fill = $104.42

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ASTAGRAF XL 0.5 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tacrolimus extended-release capsules, under the trade name “ASTAGRAF XL”.

FDA gives its dosage form as capsule, coated, extended release and its route as oral.

The labeler, the company named on the label, is Astellas Pharma US, Inc.

FDA’s Established Pharmacologic Class for it is Calcineurin Inhibitor Immunosuppressant.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00469-0647-73.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $86.45 for 30 capsules (30 × $2.88173 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name tacrolimus extended-release capsules with ASTAGRAF XL 0.5 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
ASTAGRAF XL 0.5 MG CAPSULE this page
brand · capsule, coated, extended release
$2.88173 per EA filed
eff. 2026-09-23
$9.05312 per EA filed
Part D 2024 average
ASTAGRAF XL 1 MG CAPSULE
brand · capsule, coated, extended release
$5.70907 per EA filed
eff. 2026-09-23
$9.05312 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $2.88173 per EA filed.

Of the 19 other products in FDA’s Calcineurin Inhibitor Immunosuppressant class priced per EA, 10 have a higher middle NADAC price and 9 a lower one. The one in the middle is NEORAL 25 MG GELATIN CAPSULE, at $2.94566 per EA filed (eff. 2026-07-08).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-08, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $271.59 for 30 capsules, at an average of $9.05312 per EA in 2024 (2024-01-01 to 2024-12-31) for “Astagraf XL” and “Tacrolimus”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 703 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ASTAGRAF XL 0.5 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Astagraf XL / Tacrolimus: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.